Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 99(1): 59-64, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1535091

ABSTRACT

In this study, we investigated whether mice given ultraviolet (UV)-B (280-320 nm) radiation in doses sufficient to alter cutaneous immune cells and impair the induction of contact hypersensitivity would also have impaired resistance to infectious agents administered at the site of UV irradiation. C3H mice were exposed to 400 J/m2 UVR from FS40 sunlamps on four consecutive days. Immediately after the last UV treatment, groups of mice were injected subcutaneously with Candida albicans, injected intradermally (ID) with Mycobacterium bovis bacillus Calmette-Guerin (BCG), or infected percutaneously with Schistosoma mansoni in UV-irradiated skin. The induction of the delayed hypersensitivity response to C. albicans and BCG, as assessed by footpad swelling, was unaffected by UV irradiation. However, the number of viable mycobacteria recovered from the lymphoid organs of BCG-infected mice was increased significantly in the UV-irradiated animals for a period of more than 2 months. Low-dose UV irradiation of the skin at the site of infection did not influence the number of S. mansoni parasites recoverable from the internal organs of mice that had been infected with cercariae percutaneously 6 weeks earlier. We conclude that the ability of UV radiation to impair the development of cell-mediated immunity to antigens introduced in a UV-irradiated site is not universal and depends on the particular antigen administered. We hypothesize that the involvement of epidermal Langerhans cells as the primary antigen-presenting cells in the induction of cell-mediated immunity may be the critical factor in determining whether a particular immune response will be affected by local UV irradiation.


Subject(s)
Candida albicans/radiation effects , Dermatitis, Contact/etiology , Mycobacterium bovis/radiation effects , Schistosoma mansoni/radiation effects , Animals , Candida albicans/immunology , Candidiasis/radiotherapy , Cell Count/radiation effects , Dendritic Cells/radiation effects , Dermatitis, Contact/radiotherapy , Disease Models, Animal , Drug Eruptions/etiology , Female , Hypersensitivity, Delayed/radiotherapy , Mice , Mice, Inbred C3H , Oxazolone/adverse effects , Schistosomiasis mansoni/radiotherapy , Tuberculosis/radiotherapy , Tuberculosis/veterinary , Ultraviolet Rays
2.
J Invest Dermatol ; 89(3): 230-3, 1987 Sep.
Article in English | MEDLINE | ID: mdl-3040867

ABSTRACT

When UVB-irradiated urocanic acid, the putative photoreceptor/mediator for UVB suppression, is administered to mice it induces a dose-dependent suppression of the delayed-type hypersensitivity response to herpes simplex virus, type 1 (HSV-1), of similar magnitude to that induced by UV irradiation of mice. In this study, the efferent suppression of delayed-type hypersensitivity by UV-irradiated urocanic acid is demonstrated to be due to 2 phenotypically distinct T cells, (Thy1+, L3T4-, Ly2+) and (Thy1+, L3T4+, Ly2-). The suppression is specific for HSV-1. This situation parallels the generation of 2 distinct T-suppressor cells for HSV-1 by UV irradiation of mice and provides further evidence for the involvement of urocanic acid in the generation of UVB suppression.


Subject(s)
Hypersensitivity, Delayed/prevention & control , Imidazoles/therapeutic use , Simplexvirus/immunology , T-Lymphocytes/physiology , Ultraviolet Rays , Urocanic Acid/therapeutic use , Animals , Female , Hypersensitivity, Delayed/immunology , Hypersensitivity, Delayed/radiotherapy , Immune Tolerance/drug effects , Male , Mice , Phenotype , Spleen/cytology , Spleen/transplantation , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , Urocanic Acid/radiation effects
SELECTION OF CITATIONS
SEARCH DETAIL
...